Skip Navigation

Treatment of Recurrent Esophageal Cancer

For information about the treatments listed below, see the Treatment Option Overview section.

Treatment of recurrent esophageal cancer may include the following:

  • Use of any standard treatments as palliative therapy to relieve symptoms and improve quality of life.
  • Immunotherapy with immune checkpoint inhibitors (nivolumab and ipilimumab).
  • Immunotherapy with an immune checkpoint inhibitor (nivolumab) and chemotherapy.
  • Clinical trials.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.